/PRZWT/DONGGUAN, Dec. 19, 2024 - The launch of the Dongguan Biology Month on Dec. 3 brought the Songhu Pharmaceutical Port Industrial Park, developed and operated by a wholly state-owned enterprise, into the public eye for the first time.
After more than ten years of development, Dongguan's biomedical industry has gathered more than 500 biological enterprises, and the industrial ecology has become increasingly mature. After taking the development from 0 to 1, why did Dongguan build Songhu Pharmaceutical Port, a park with the goal of "Dongguan Biomedical Industry Gateway"?
"Songhu Pharmaceutical Port will keep an eye on innovative, entrepreneurial and high-growth biomedical enterprises, adhere to the simultaneous development of'chain building, strong chain, supplementary chain and expansion ', and adopt'radar' type investment promotion and'magnetic core 'type to attract business. It will build a vertical ecosystem of biomedical industry research and development, incubation, pilot production, clinical registration and industrialization, and become the source of the accelerated development of Dongguan's biomedical industry." As a pioneer and witness of Dongguan's biomedical industry, Song Tao, executive chairperson of Dongguan Biotechnology Industry Association and chairperson of Dongguan Biotechnology Industry Development Co., Ltd., said.
Songhu Pharmaceutical Port has created an internal and external dual-cycle model of "core industry + upstream and downstream supporting of the industrial chain + capital pool", which helps every link of the development of biological enterprises to realize the deep integration and development of the industrial chain, innovation chain, talent chain and capital chain, and seize this "never-ending" sunrise industry trend to help Dongguan develop with high quality.
Changes in Time: Seizing Opportunities for the Development of the Biomedical Industry
On December 3rd, the "Ecological Collaboration to Promote New Quality Industry Symbiosis" 2024 Dongguan Biomedical Technology and Industry Promotion Month Launching Conference and the Grand Launch of the Five Key Biomedical Parks, Songhu Pharmaceutical Port was officially opened!
As an important fulcrum to promote the development of Dongguan's biomedical industry from 1 to N, the opening of Songhu Pharmaceutical Port has attracted wide attention!
Since 2012, in Dongguan, a city founded on manufacturing, the biomedical industry has begun to enter relevant government documents. It is also at this stage that Dongguan has laid the foundation for Dongguan's biological industry from 0 to 1 by establishing a cross-strait biotech industry cooperation base in Dongguan, establishing the city's only state-owned biotech industry platform, Dongguan Biotechnology Industry Development Co., Ltd., and establishing a global investment network, introducing an industrial public service platform, conducting strategic investments, and holding industry events.
This stage of the agglomeration and development of Dongguan's biomedical industry is also a golden period for the development of China's biomedical industry. Data show that from 2010 to 2020, the total output value of our country's pharmaceutical industry has increased from 1 trillion yuan to 10 trillion yuan, 10 times in 10 years, which is the "golden decade" of our country's pharmaceutical industry.
Since the beginning of this year, China's biomedical industry has entered a new stage of development, experiencing a transformation from Chinese manufacturing to Chinese creation, and from imitation to innovation. At the Guangdong level, the provincial government has issued the "Action Plan on Further Promoting the High-quality Development of Guangdong's Biomedical Industry", calling for increased support for the entire chain of innovative pharmaceutical equipment and playing the main theme of innovation in an all-round way.
Dongguan has seized the period of vigorous development of the biomedical industry and completed the accumulation from 0 to 1. Up to now, Dongguan has gathered more than 500 biological enterprises, and its industrial ecology is becoming more and more mature. It has initially formed the aggregation and common development of multiple industrial chains such as innovative drugs and high-end generic drugs, medical apparatus, in vitro diagnostics, stem cells and regenerative medicine. Leading enterprises in many industrial sub-sectors such as Dongyang Pharmaceutical, Sansheng Pharmaceutical, Feipeng Bio, Pumen Technology, Bomai Medical, Modern Dentistry, Anjian Technology, Wanfu Bio, etc., have established a number of biomedical industry public service platforms.
Biomedicine is a comprehensive discipline that integrates multiple disciplines such as biology, medicine, biotechnology, and pharmacy. Its research scope is very wide, covering a wide range of fields from basic medicine to clinical medicine, preventive medicine, and rehabilitation medicine. The biomedical industry focuses on the study of human structure, physiological functions, and disease mechanisms, and is committed to the development of new theories, new technologies, new methods, and new products in the fields of prevention, diagnosis, treatment, and rehabilitation.
At the same time, under the trend that the development of the biomedical industry is becoming more and more complex and specialized, and the investment promotion of multiple cities in China is becoming more and more internal, the development of the biomedical industry in Dongguan also urgently needs new tricks to accelerate the agglomeration and development of the biomedical industry on the basis of the existing industry, and contribute to the high-quality development of Dongguan.
It is against this background that Songhu Pharmaceutical Port has changed in Dongguan in response to the times, and taking the initiative is also an inevitable path for the development of Dongguan's biomedical industry to usher in innovation.
Homeopathy: Create a double-loop model inside and outside
Songhu Pharmaceutical Port Industrial Park is a wholly state-owned enterprise Dongguan Biotechnology Industry Development Co., Ltd., an ecological technology and garden-style biological theme park combining natural mountain landscapes. It is positioned as the central park of Dongguan's biotechnology industry and will provide biomedical enterprises with a diverse product space covering R & D offices, small and medium-scale pilot production, corporate headquarters, business facilities, and secondary production and related industrial facilities, dormitories, etc.
The park will create an internal and external dual-cycle model of "core industry + upstream and downstream supporting of the industrial chain + capital pool", which will help every link of the development of biological enterprises to achieve the deep integration of the "four chains" such as the industrial chain, innovation chain, talent chain, and capital chain.
More specifically, Songhu Pharmaceutical Port will create six major platforms, including industrial public platform services, industrial fund services, resource linking services, talent exchange services, display exchange services, and intermediary comprehensive services, to assist the development of biomedical enterprises and promote the development of biomedical enterprises from going it alone to agglomeration. This will help Dongguan's biomedical industry move towards the high end of the value chain and industrial chain.
Among them, in terms of industrial public platform services, Songhu Pharmaceutical Port will build a biomedical R & D and achievement transformation research institute, a bioengineering achievement transformation and service center, a stem cell and regenerative medicine pilot platform, and a biomedical outsourcing CXO platform to create a vertical ecosystem of R & D, incubation, pilot production, clinical registration, and industrialization.
CXO is a collective term for CRO, CMO, CDMO, CSO, etc. It intervenes in the entire industrial chain of the pharmaceutical industry through outsourcing, covering R & D, production, sales and other links. Under the current trend of increasingly complex and specialized development of the biomedical industry, CXO has become an important bridge linking the upstream and downstream industrial chains of the biomedical industry.
In terms of industrial fund services, Songhu Pharmaceutical Port has established a biological industry fund with well-known biological enterprises and investment institutions such as Da'an Gene, Boji Pharmaceutical, and Zhongqi Capital, with a scale of over 1 billion yuan; at the same time, it has established a biomedical service base of Songshan Lake Science and Technology Financial Service Center, which has gathered a group of banks, Private Equity institutions and fund management companies and other investment and financing service institutions to provide financial support and guarantee for the development of enterprises throughout the life cycle. In terms of industrial services, Songhu Pharmaceutical Port will support the construction of hotels, commercial, multi-functional conference rooms and industrial meeting rooms to provide a full range of industrial services.
At the same time, the establishment of Dongguan biomedicine and health industry service station, gathered a number of biomedical industry institutions settled in, for Dongguan biomedical enterprises to provide government and enterprise services, consulting services, policy interpretation, technology transfer, training and other industry services, has settled in the industry intermediaries include: Hong Kong Biotechnology Association, Greater Bay Area Medical Professional Development Association, Guangdong Medical Apparatus Industry Association, Dongguan Biotechnology Industry Association, Dongguan Medical Apparatus Industry Association, Songshan Lake Modern Biomedical Industry Technology Research Institute, etc.
At present, Songhu Pharmaceutical Port conforms to the tide of high-quality development of the biomedical industry in Dongguan, actively builds a more complete industrial ecosystem, and contributes the strength of Dongguan biotech people to achieve a leap from 1 to N for the biomedical industry in Dongguan.
